
224.20 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 180.93 Today|||52-Week Range 348.67 | +0.78% Year-to-Date |
Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report? Dec 06 / Zacks.com - Paid Partner Content | Penumbra (PEN) Enrolls First Patient in Landmark STORM-PE Trial Nov 30 / Zacks.com - Paid Partner Content |
Wall Street Analysts See a 26.89% Upside in Penumbra (PEN): Can the Stock Really Move This High? Nov 30 / Zacks.com - Paid Partner Content | Penumbra's (PEN) Expansion Moves, New Launches Aid Growth Nov 28 / Zacks.com - Paid Partner Content |
Previous close | 223.19 |
Today’s open | 223.60 |
Day’s range | 221.14 - 224.45 |
Volume | 279,165 |
Average volume (3 months) | 408,383 |
Market cap | $8.8B |
Earnings growth (last year) | -136.81% |
Earnings growth (this year) | +891.98% |
Earnings growth (next 5 years) | +20.00% |
Revenue growth (last year) | +13.32% |
P/E ratio | 213.4 |
Price/Sales | 9.94 |
Price/Book | 8.67 |
Today’s change | Today’s % change | |
---|---|---|
SWAVShockwave Medical In... | -0.80 | -0.46% |
TFXTeleflex Inc | -1.56 | -0.67% |
---- | ||
HAEHaemonetics Corp | +1.56 | +1.87% |
Next reporting date | February 27, 2024 |
EPS forecast (this quarter) | $0.61 |
Annual revenue (last year) | $847.1M |
Annual profit (last year) | -$2.0M |
Net profit margin | -0.24% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Alameda, California |